Clinical Trial Update: Evaluation of Immunogenicity and Safety of Human Papillomavirus (HPV) Vaccine Co-administered With Another Vaccine in Healthy Female Subjects [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating immunogenicity and safety of HPV vaccine co-administered with another vaccine in healthy female subjects; completed with results posted…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hpv-related Diseases
• Human Papillomavirus Infection
• Infections Papillomavirus

Drugs mentioned

• HPV vaccine

Snippet

Sponsor: GlaxoSmithKline | Conditions: Infections, Papillomavirus | Phase 3 | Status: COMPLETED | Results posted: 2010-08-31